Bilateral Initial Margin for Non-Cleared OTC Derivatives

Bilateral Initial Margin for Non-Cleared OTC Derivatives

Connecting front office, treasury and operations, MX.3 for Bilateral Initial Margin addresses the IM funding challenge. It meets compliance needs along the full calculation chain while supporting long-term growth. A flexible and open solution, it smooths the path to regulatory approval and helps you to improve decision-making.